General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash from operating activities:        
Net loss $ (8,080,819) $ (5,912,356) $ (6,864,783) $ (6,008,901)
Adjustments to reconcile net loss to net cash used in operating activities:        
Bad debt expense     0 76,046
Depreciation and amortization 393,057 225,825 350,192 275,346
Loss on disposal of assets     14,454
Stock based compensation 499,590 592,177 819,191 262,411
Stock issued for services 105,565 120,000 157,500 144,167
PPP loan forgiveness including accrued interest     (1,421,577)
Amortization of operating lease right of use asset 235,217 198,790 235,834 250,482
Changes in assets and liabilities:        
   Accounts receivable 3,159,389 (454,431) (1,679,720) (611,023)
   Note receivable (151,875)    
   Contract assets (921,009) (820,938) (422,273) 99,009
   Inventory (97,552) (395,787) (1,130,022) (185,915)
   Prepaid expenses and other current assets 543,793 15,539 266,539 423,905
   Security deposit 50,000 (600,000)
   Accounts payable (1,670,625) 605,129 1,245,890 445,184
Accounts payable-related party     (7,700)
Payroll taxes payable     (3,146)
   Accrued expenses (178,081) (136,180) (165,069) (408,692)
   Operating lease obligation (154,653) 60,668 184,728 (127,816)
   Contract liabilities 630,931 2,051,109 (871,314) 804,388
Net cash used in operating activities (5,637,072) (3,850,455) (7,873,307) (6,579,378)
Cash flows from investing activities:        
    Purchase of patents/trademarks (58,208) (17,490) (18,190) (7,435)
    Purchase of software development (640,609) (87,700) (281,783)
    Purchase of fixed assets (199,618) (311,327) (344,915) (545,505)
Net cash used in investing activities (898,435) (416,517) (644,888) (552,940)
Cash flows from financing activities:        
   Repayments of insurance and equipment financing (395,221) (303,492) (331,175) (353,444)
   Repayment of finance lease (22,851) (69,325) (80,335) (89,618)
   Proceeds from common stock issued 8,550,002 8,801,003
   Stock issuance cost (17,645) (837,467) (942,926)
   Proceeds from shares issued under Employee Stock Purchase Plan 117,048    
   Proceeds from preferred stock issued 9,000,000 999,000 1,299,000 4,500,000
Net cash provided by financing activities 8,681,331 8,338,718 8,745,567 4,056,938
Net increase in cash 2,145,824 4,071,746 227,372 (3,075,380)
Cash, beginning of period 1,121,092 893,720 893,720 3,969,100
Cash, end of period 3,266,916 4,965,466 1,121,092 893,720
Supplemental Disclosure of Cash Flow Information:        
Interest paid 5,816 8,045 9,292 30,817
Taxes paid 1,264 1,264
Supplemental Non-Cash Investing and Financing Activities:        
Lease right of use asset and liability     4,980,104
Notes issued for financing of insurance premiums $ 458,452 $ 353,244 $ 353,244 $ 363,005